Issue 6, 2013

Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening

Abstract

In this study, 22 novel hFTase inhibitors containing 18 scaffolds were identified with IC50 values ranging from 0.0119 to 13.35 μM by structure-based virtual screening, and compounds 2, 7, 9, 10, 14 and 15 showed moderate antiproliferative activity against MCF-7 cells. In particular, compound 2 was the most promising lead compound with nanomolar activity against FTase and antiproliferative activity in the low micromolar range. Possible binding modes of the hit compounds were explored and their structure–activity relationships (SAR) were elucidated by molecular docking simulation. The hit compounds discovered in this work will provide novel scaffolds for further hit-to-lead optimization and lay the foundation for further development of therapeutic candidates for cancer treatments.

Graphical abstract: Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening

Supplementary files

Article information

Article type
Concise Article
Submitted
21 Feb 2013
Accepted
10 Apr 2013
First published
10 Apr 2013

Med. Chem. Commun., 2013,4, 962-971

Discovery of novel inhibitors for human farnesyltransferase (hFTase) via structure-based virtual screening

X. Yu, X. Zhao, L. Zhu, C. Zou, X. Liu, Z. Zhao, J. Huang and H. Li, Med. Chem. Commun., 2013, 4, 962 DOI: 10.1039/C3MD00058C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements